3-(Pyridin-4-yl)-1H-pyrazole-4-carbaldehyde

Catalog No.: 
ACZTPB801
CAS No.: 
1152541-94-0
Molecular Formula: 
C9H7N3O
Molecular Weight: 
173.18
3-(Pyridin-4-yl)-1H-pyrazole-4-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$202.00InquiryInquiry
5g98%$990.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Pyridin-4-yl)-1H-pyrazole-4-carbaldehyde
IUPAC Name3-(pyridin-4-yl)-1H-pyrazole-4-carbaldehyde
MDL No.MFCD08751327
Molecular FormulaC9H7N3O
Molecular Weight173.18
SMILESO=CC1=CNN=C1C2=CC=NC=C2
InChI KeyASLOUQXKVUKLNX-UHFFFAOYSA-N
Synonym3-PYRIDIN-4-YL-1H-PYRAZOLE-4-CARBALDEHYDE;1H-Pyrazole-4-carboxaldehyde, 3-(4-pyridinyl)-;3-(4-Pyridyl)-1H-pyrazole-4-carbaldehyde
CAS No.1152541-94-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZTPB801 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1In Stock
  4. Then
  5. ACZTPB801 route product structure diagram
    ACZTPB8011152541-94-0
Inquiry

2. ACZTPB801 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1In Stock
  4. Then
  5. ACZTPB801 route product structure diagram
    ACZTPB8011152541-94-0
Inquiry

3. ACZTPB801 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZTPB801 route product structure diagram
    ACZTPB8011152541-94-0
Inquiry

Comments (0)